Goldman Sachs’ 6 Top Trade Ideas For The Coming Year
A team at Goldman Sachs has released its first set of top trade ideas for 2017, representing a mix of continuing existing calls from the…
Zenect Wealth
Bank of America’s 24 Best Stocks For “Superior Investment Performance”
“Providing superior investment performance over the long term”. This is the goal of Bank of America Merrill Lynch’s US 1 list, which represents the bank’s…
Has Trump Made Mexico “A Screaming Buy”?
Today’s article notes that while many investors have been flocking to sectors expected to benefit from a Trump presidency, others have been looking for areas…
The Energy Investor’s Guide To The Trump Presidency
Among the various policy areas that are about to undergo the most radical of shifts with the transfer of the executive branch from President Obama…
The “Secret Stock Weapon” That Can Prevent Dividend Dreams From Becoming Dividend Nightmares
In the current low interest-rate environment, dividend-paying stocks have been getting a lot of love from yield-starved investors. However, as today’s article emphasizes, 525 companies…
4 Biotechs To Consider On The Sector’s Trump Turnaround
After being weighted down this year by the prospect of a Hillary Clinton administration focused on curbing drug prices, biotechs have seen a recovery since…
“Monster Moves”: 5 Stocks Under $10 Moving Towards Breakout Trades
“There isn’t a day that goes by on Wall Street when certain stocks trading under $10 a share don’t experience massive spikes higher,” notes the…
Growth v. Value: Which Type Of Stock Wins When…And Why
“Value stocks are beating the pants off of growth stocks this year,” states the author of today’s article which examines the competition between these two…
3 Healthcare Stocks That Could Win Bigly – Or Big League – Under President Trump
While today’s article was written before the election and its shocking upset, the author had the foresight to ignore the polls, pundits and public expectations…
The Ballot Measure That Worries Pharmaceutical Companies (And Pharma-Stock Investors) More Than A Clinton Victory
While it is widely agreed upon that a Hillary Clinton election victory would be bad news for pharmaceutical stocks due to her promise to tackle…